Top section
Top section
High yields and tight senior/sub spread fuel enthusiasm for issuance among investors and issuers
◆ Pair help market to end week on a high note ◆ GSK offers pick-up over peer AstraZeneca ◆ Glencore finds demand at eight years
◆ French borrower takes €1.15bn across two tranches ◆ Balance struck between size and price to keep investors onside ◆ Small concession offered
Data
More articles
More articles
More articles
-
◆ Price sensitivity returns as deal premium shrinks ◆ Final book dropped by more than half ◆ Deal did not go as well as TfL's sterling trade, say bankers -
◆ Oversubscription lets leads skip guidance ◆ New issue premium in low single digits ◆ Solid bid despite CEO uncertainty
-
Guidance slashed but still a rare chance to earn 10% in primary market
-
Banks, infrastructure, urban development and the energy transition all areas of focus
-
◆ Some investors pass over ESG but other factors prove a lure ◆ Orderbook more than three times deal size at peak ◆ Attrition as spread tightened
-
◆ French utility skips guidance, boosts size ◆ Bid eradicates new issue premium ◆ P3 Group adds to green slate with a €500m 7.5 year
Sub-sections
